BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 35418161)

  • 21. Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.
    Sun H; Liu M; Sun T; Chen Y; Lan Z; Lian B; Zhao C; Liu Z; Zhang J; Liu Y
    Behav Brain Res; 2019 Dec; 376():112182. PubMed ID: 31472195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes.
    Hernandez D; Sugaya K; Qu T; McGowan E; Duff K; McKinney M
    Neuroreport; 2001 May; 12(7):1377-84. PubMed ID: 11388415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
    Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
    Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation.
    Wenk GL; McGann-Gramling K; Hauss-Wegrzyniak B
    Neuroscience; 2004; 125(3):769-76. PubMed ID: 15099690
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function.
    Gibbs RB
    Exp Neurol; 1998 Jun; 151(2):289-302. PubMed ID: 9628764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.
    Wilson EN; Do Carmo S; Welikovitch LA; Hall H; Aguilar LF; Foret MK; Iulita MF; Jia DT; Marks AR; Allard S; Emmerson JT; Ducatenzeiler A; Cuello AC
    J Alzheimers Dis; 2020; 73(2):723-739. PubMed ID: 31868669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM; Lopez-Picon FR; Serrière S; Wang R; Bochicchio D; Webb SD; Vandesquille M; Harte MK; Georgiadou C; Lawrence C; Busson J; Vercouillie J; Tauber C; Buron F; Routier S; Reekie T; Snellman A; Kassiou M; Rokka J; Davies KE; Rinne JO; Salih DA; Edwards FA; Orton LD; Williams SR; Chalon S; Boutin H
    Theranostics; 2021; 11(14):6644-6667. PubMed ID: 34093845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats.
    Nakamura N; Fujita H; Kawata M
    Neuroscience; 2002; 109(3):473-85. PubMed ID: 11823060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magnetic resonance spectroscopy analysis of neurochemical changes in the atrophic hippocampus of APP/PS1 transgenic mice.
    Liang S; Huang J; Liu W; Jin H; Li L; Zhang X; Nie B; Lin R; Tao J; Zhao S; Shan B; Chen L
    Behav Brain Res; 2017 Sep; 335():26-31. PubMed ID: 28797599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
    Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
    J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's disease: Targeting the Cholinergic System.
    Ferreira-Vieira TH; Guimaraes IM; Silva FR; Ribeiro FM
    Curr Neuropharmacol; 2016; 14(1):101-15. PubMed ID: 26813123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Different cholinergic cell groups in the basal forebrain regulate social interaction and social recognition memory.
    Okada K; Nishizawa K; Kobayashi T; Sakata S; Hashimoto K; Kobayashi K
    Sci Rep; 2021 Jun; 11(1):13589. PubMed ID: 34193944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and β-amyloid.
    Deibel SH; Weishaupt N; Regis AM; Hong NS; Keeley RJ; Balog RJ; Bye CM; Himmler SM; Whitehead SN; McDonald RJ
    Brain Res; 2016 Sep; 1646():12-24. PubMed ID: 27208489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic neurodegeneration in an Alzheimer mouse model overexpressing amyloid-precursor protein with the Swedish-Dutch-Iowa mutations.
    Foidl BM; Do-Dinh P; Hutter-Schmid B; Bliem HR; Humpel C
    Neurobiol Learn Mem; 2016 Dec; 136():86-96. PubMed ID: 27670619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fas-associated factor 1 promotes in neurofibrillary tangle-mediated cell death of basal forebrain cholinergic neurons in P301L transgenic mice.
    Kim JM; Kim SS; Lee YD
    Neuroreport; 2015 Sep; 26(13):767-72. PubMed ID: 26164610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
    Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
    Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection of Cholinergic Neurons with a Tau Aggregation Inhibitor and Rivastigmine in an Alzheimer's-like Tauopathy Mouse Model.
    Zadrozny M; Drapich P; Gasiorowska-Bien A; Niewiadomski W; Harrington CR; Wischik CM; Riedel G; Niewiadomska G
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral Administration of Gintonin Attenuates Cholinergic Impairments by Scopolamine, Amyloid-β Protein, and Mouse Model of Alzheimer's Disease.
    Kim HJ; Shin EJ; Lee BH; Choi SH; Jung SW; Cho IH; Hwang SH; Kim JY; Han JS; Chung C; Jang CG; Rhim H; Kim HC; Nah SY
    Mol Cells; 2015 Sep; 38(9):796-805. PubMed ID: 26255830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focused ultrasound-induced blood-brain barrier opening improves adult hippocampal neurogenesis and cognitive function in a cholinergic degeneration dementia rat model.
    Shin J; Kong C; Lee J; Choi BY; Sim J; Koh CS; Park M; Na YC; Suh SW; Chang WS; Chang JW
    Alzheimers Res Ther; 2019 Dec; 11(1):110. PubMed ID: 31881998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.